US FDA approves Regeneron's 8-mg dose of eye disease drug Eylea
The U.S. Food and Drug Administration approved the 8-mg dose of Regeneron Pharmaceuticals' eye disease drug Eylea, the
1970-01-01 08:00
US FDA approves Regeneron's ultra-rare blood disease drug
(Reuters) -Regeneron Pharmaceuticals said on Friday the U.S. health regulator approved its drug to treat a rare blood disease. The
1970-01-01 08:00
US FDA declines to approve Regeneron high-dose Eylea
The U.S. Food and Drug Administration on Tuesday declined to approve a higher-dose version of Regeneron Pharmaceuticals' blockbuster
1970-01-01 08:00